Snowball logo
logo
BGLC

BioNexus Gene Lab Corp Common stock

BGLC โ€ข NASDAQ
$1.60-$0.04ย  (2.44%)
Estimate
EPS
-1.43
Beta
2.189
Growth
Revenue, YoY
-98.93%
Net income, YoY
12.79%
FCF, YoY
82.24%
About the company
Ticker
BGLC
ISIN
US0906283066
Country
Malaysia
Sector (GICS)
Materials
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Frequently asked questions

What sector does BioNexus Gene Lab Corp Common stock (BGLC) operate in?

BioNexus Gene Lab Corp Common stock belongs to the Materials sector and operates in the Specialty Chemicals industry.

What is BioNexus Gene Lab Corp Common stock (BGLC) current stock price?

As of the latest data, BioNexus Gene Lab Corp Common stock stock price is $1.60, with a previous close of $1.64. BioNexus Gene Lab Corp Common stock lost -$0.04 in the last trading session, representing a -2.44% loss.

What is BioNexus Gene Lab Corp Common stock (BGLC) current market capitalization?

BioNexus Gene Lab Corp Common stock market cap is approximately 3.87 million.

What is BioNexus Gene Lab Corp Common stock (BGLC) Earnings Per Share (EPS)?

The trailing EPS is -$1.43.

What is BioNexus Gene Lab Corp Common stock (BGLC) EBITDA?

BioNexus Gene Lab Corp Common stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -496.61 thousand.

Does BioNexus Gene Lab Corp Common stock (BGLC) pay dividends?

No. BioNexus Gene Lab Corp Common stock does not pay a dividend.

When is BioNexus Gene Lab Corp Common stock (BGLC) next earnings report?

BioNexus Gene Lab Corp Common stock is expected to release its next earnings report on June 30, 2026.

What is BioNexus Gene Lab Corp Common stock (BGLC) beta (volatility) score?

BioNexus Gene Lab Corp Common stock has a beta of 2.189, indicating very high volatility compared to the market.